of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation. Physiol Genomics 44: [183][184][185][186][187][188][189][190][191][192][193][194][195][196][197] 2012. First published December 6, 2011; doi:10.1152 doi:10. /physiolgenomics.00093.2011genesis is a tightly controlled process involving the transcriptional activation and repression of thousands of genes. Although many components of the transcriptional network regulating the later phases of myogenesis have been identified, relatively few studies have described the transcriptional landscape during the first 24 h, when myoblasts commit to differentiate. Through dense temporal profiling of differentiating C2C12 myoblasts, we identify 193 transcriptional regulators (TRs) whose expression is significantly altered within the first 24 h of myogenesis. A high-content shRNA screen of 77 TRs involving 427 stable lines identified 42 genes whose knockdown significantly inhibits differentiation of C2C12 myoblasts. Of the TRs that were differentially expressed within the first 24 h, over half inhibited differentiation when knocked down, including known regulators of myogenesis (Myod1, Myog, and Myf5), as well as 19 TRs not previously associated with this process. Surprisingly, a similar proportion (55%) of shRNAs targeting TRs whose expression did not change also inhibited C2C12 myogenesis. We further show that a subset of these TRs inhibits myogenesis by downregulating expression of known regulatory and structural proteins. Our findings clearly illustrate that several TRs critical for C2C12 myogenesis are not differentially regulated, suggesting that approaches that focus functional studies on differentially-expressed transcripts will fail to provide a comprehensive view of this complex process. myogenesis; shRNA; microarray; transcription; time course; gene expression SKELETAL MUSCLE IS FORMED when somite-derived progenitor cells (myoblasts) undergo terminal differentiation and fuse into long multinucleated myotubes. As part of this process, myoblasts follow epigenetic and environmental cues to undergo sequential steps involving exit from the cell cycle, alignment of the differentiating myoblasts and fusion into myotubes (11, 35) . Pioneering experiments in the transcriptional regulation of cell differentiation have shown that myogenesis is regulated by the basic helix-loop-helix (bHLH) and MADS-box families of transcription factors. Specification is attributed to Myod1 and Myf5, two bHLH factors that share redundant function and are expressed in proliferating myoblasts (38), while terminal differentiation is regulated by Myog, another member of the bHLH family that is expressed at a later stage of the differentiation program (12, 54). Additionally, genes belonging to the MEF2 family of MADS-box factors, particularly Mef2c, potentiate the muscle phenotype but, as with Myog, are not able to specify myogenesis alone (12, 30) . Together, these transcription factors, while essential to the entire process of muscle differentiation, have been shown to regulate large sets of distinct and sometimes overlapping targets (6, 36), but appear to be functionally required for either specification (early) or terminal differentiation (late).
transcription factors. Specification is attributed to Myod1 and Myf5, two bHLH factors that share redundant function and are expressed in proliferating myoblasts (38) , while terminal differentiation is regulated by Myog, another member of the bHLH family that is expressed at a later stage of the differentiation program (12, 54) . Additionally, genes belonging to the MEF2 family of MADS-box factors, particularly Mef2c, potentiate the muscle phenotype but, as with Myog, are not able to specify myogenesis alone (12, 30) . Together, these transcription factors, while essential to the entire process of muscle differentiation, have been shown to regulate large sets of distinct and sometimes overlapping targets (6, 36) , but appear to be functionally required for either specification (early) or terminal differentiation (late).
To date, there have been few genome-wide studies investigating the events leading to the fused muscle state, especially with regard to profiling changes in gene expression that occur within the first 24 h of myogenesis. Several DNA microarray studies have characterized the global trends of expression changes that occur during myogenesis in transformed and primary cultures (31, 41, 48, 51) . The time-series analyses described in these studies were performed at intervals of 1 or more days and tracked the major waves of gene expression occurring during differentiation. In parallel, two reports used proteomics methods to track protein expression changes during myogenesis and found that protein and transcript temporal profiles were similar for Ͼ90% of genes (24, 50) , which suggests that the process is mostly regulated at the transcriptional level. Delgado et al. (14) published a report investigating changes that occur at seven time points within the first 24 h of differentiation using duplicate arrays; 1,500 genes were identified as being differentially expressed and were clustered into 12 groups of co-ordinately expressed genes. While the large number of genes implicated clearly highlighted the importance of studying the early phase, the authors did not estimate how many of these genes are actually required for C2C12 myogenesis.
It is clear from all of these studies that massive transcriptional changes occur during myogenesis. However, only a fraction of these changes are directly regulated by binding of Myod1, Myog, and Mef2 transcription factors (6) , suggesting that many important early regulators are as yet unknown. A thorough description of early transcriptional events is therefore needed to identify genes that could either extend the list of regulators for the process, or elucidate mechanisms through which known regulators are activated.
In this study, we extended these previous approaches by conducting a large-scale microarray study of the transcriptional changes that occur during differentiation of the classical C2C12 myoblast model, paying particular emphasis to expression changes in the early phase. We used high-density gene expression arrays to profile C2C12 myogenesis at 14 time points and identified 193 transcriptional regulators (TRs) as being differentially expressed within the first 24 h of differentiation. Using next-generation shRNA libraries, we interrogated how this program of gene expression ultimately contributes to muscle differentiation and identified 42 factors that were essential to C2C12 myogenesis. Interestingly, this included 19 TRs that were not previously implicated in C2C12 differentiation, as well as 12 TRs that were not differentially expressed during C2C12 differentiation yet were also essential for this process to occur. Three of these TRs were followed up and shown to be required for expression of Mef2c and Troponin T1. This study therefore improves our knowledge of myogenesis by extending the list of TRs required for C2C12 differentiation and offers insight into a more systems-oriented view of transcriptional regulation in this process.
Availability of data. All DNA microarray results have been uploaded to the Gene Expression Omnibus under the SuperSeries accession number GSE17039.
MATERIALS AND METHODS
Cell culture. C2C12 myoblasts (ATCC CRL-1772) were cultured until passage 4 in DMEM containing 20% FBS before which they were split into 19 15-cm plates (1 ϫ 10 5 cells/plate). Three of these plates were split again after 3 days for subsequent replicates while the remaining plates were harvested in 1.5 ml Tri Reagent (Invitrogen, Burlington, ON, Canada) at 13 time points. Differentiation was induced at t ϭ 0 by changing the medium to DMEM containing 2% horse serum (Gibco).
RNA sample preparation. Total RNA was extracted using phenol/ chloroform extraction, followed by ethanol precipitation. All expression analysis was performed at the Functional Genomics core facility of the Genome Quebec and McGill University Innovation Centre (Montreal, QC, Canada). Extracted RNA samples were purified using RNEasy mini columns (Qiagen, Valencia, CA), and total RNA was quantified on a ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE). RNA quality was estimated by using the RNA 6000 Nano assay in the Agilent Bioanalyzer monitoring for ribosomal 28S/18S RNA ratio (Agilent Biotechnologies, Mississauga, ON, Canada). Each sample of extracted RNA was then separated into three streams: one stream for processing on Affymetrix arrays, one for Illumina arrays, and one for RT-PCR cross-validation.
Microarray analysis on the Affymetrix platform. We labeled 5 g of total RNA based on the standard Affymetrix eukaryotic RNA labeling protocol. We fragmented 20 g of biotin-labeled cRNA based on Affymetrix' eukaryotic sample protocol. Hybridization of 10 g on MOE-430 version 2 chips, staining, and washing was performed using the Affymetrix Fluidics Station 450 and Hybridization Oven 640 under standard conditions. Images scanned on Gene Chip 3000 scanners were analyzed with Affymetrix GCOS software (Affymetrix, Santa Clara, CA).
Microarray analysis on the Illumina platform. Microarray probes were prepared using 500 ng of total RNA. cRNA amplification and labeling with biotin were performed using Illumina TotalPrep RNA amplification kit manufactured by Ambion (Austin, TX) according to the manufacturer's protocol. cRNA was quantified on a ND-1000 spectrophotometer (NanoDrop Technologies), and 1.5 g of labeled cRNA were hybridized to Sentrix Mouse-6 (WG-6v1.1) Expression Beadchips and stained according to the manufacturer's protocols. Beadchips were scanned on the Illumina BeadArray Reader confocal scanner according to the manufacturer's instructions (Illumina, San Diego, CA).
Expression array data analysis. Raw data from both platforms were processed using the FlexArray package (7) . Affymetrix expression data were normalized using robust multiarray average (RMA) (8) with background correction. Statistical analysis was performed using Cyber-T (4) comparing each time point with t ϭ 0 using a window size of 101 and confidence ratio of 10, followed by false discovery rate (FDR) adjustment of P values (21) . Genes were deemed as differentially expressed if the FDR-adjusted P values were Ͻ0.1. Significant TRs between t ϭ 0 and t ϭ 24 h were clustered by K-means using the program TMeV (40) to identify early and late TRs.
Illumina raw expression data were normalized using the LUMI algorithm (15) with RMA background adjustment, variance stabilization using VST and normalization using the robust spline normalization (RSN) method (26) .
Validation of Affymetrix expression data using Illumina expression data and RT-PCR. For comparison with Affymetrix probe sets, we mapped Illumina Probe identifiers to either Entrez Gene IDs or RefSeq IDs using the ILMN_Mouse-6v1.1_Affy_430v2.0.txt probe mapping file (downloaded from http://www.switchtoi.com/probemapping.ilmn). The sequences of the remaining unmapped probes were aligned to the mouse sequences of the RefSeq database (October 2008 build) using BLAST. Only perfect matches (expectation score ϭ 1 ϫ 10 Ϫ21 ) were considered for annotation. In cases where several probes mapped to the same gene, we chose the probe that had the higher mean (for two matching probes) or median (for more than two matching probes) expression value at t ϭ 0. Affymetrix probe sets that could cross-hybridize ("_a_at", "_s_at", "_x_at" probe sets) were excluded from analysis. The remaining probe sets were mapped to Entrez RT-PCR validation of microarray results was performed using gene-specific TaqMan Gene Expression Assays (Applied Biosystems). Eif3i was included as a control for expression levels based on its expression not changing on either microarray platform (data not shown). Primers used for analysis are listed in Table 1 . PCR reactions were performed using TaqMan universal PCR master mix (Applied Biosystems) according to the manufacturer's instructions. For validation of genes used in the lentiviral screen, reverse transcription was performed by using iScript cDNA synthesis kit (Bio-Rad, Mississauga, ON, Canada) and SYBR Green PCR was done by using the Platinum SYBR Green qPCR SuperMix-UDG with ROX master mix (Invitrogen). The 7900HT Sequence Detection System (SDS version 2.3 -Applied Biosystems) was used to record Ct values and interpolate actual RNA concentration based on a standard curve determined for each gene Ͼ5 orders of magnitude. Each reaction was performed in triplicate to ensure accurate quantification and average signals were normalized to Eif3i expression levels.
Candidate selection for lentiviral shRNA knock-down. Three sets of TRs were selected as candidates for shRNA knock-down. Target set: Probe sets mapping to TRs from either TFCAT or Ingenuity Pathways Analysis (IPA) were selected and filtered to identify genes that were significantly differentially expressed in the first 24 h of myogenesis (FDR P Ͻ 0.1). If there were multiple probe sets for the same gene symbol, only the one with the greatest range in fold change was selected. Downregulated probe sets were removed, as were probe sets that showed Ͻ1.5-fold change within the first 24 h. Negative set: Probe sets mapping to TRs from either TFCAT or IPA were selected. If there were multiple probe sets for the same gene symbol, only the one with the lowest P value was kept. Downregulated probe sets were removed, as were probe sets that were differentially expressed at any point in the study (FDR P Ͻ 0.1). Finally, probe sets were selected if they had an average expression range matching the target set, and 30 of these were randomly selected, corresponding to 21 unique TRs. Positive control set: Three genes were selected to supplement the target set based on literature knowledge supporting their role in myogenesis.
Lentiviral shRNA knock-down of candidate genes. Each gene was targeted by four or five constructs obtained from The RNAi Consortium (TRC). Lentiviral shRNA expression vectors (pLKO.1 backbone) were transfected into 293T cells in 96-well plates (Corning) using protocols from TRC (http://www.broad.mit.edu/rnai/trc/lib). Transfection efficiency was assessed at Ͼ80% from separate wells transfected with the pLJM1 construct, which contains the EGFP coding sequence within the same pLKO.1 backbone. We collected 150 l lentivirus after 24 h and subjected it to one freeze-thaw cycle at Ϫ80°C to remove any residual 293T cells. Proliferating C2C12 cells grown in DMEM ϩ 20% FBS were plated on 96-well plates (Corning) precoated with 0.15% gelatin (2 ϫ 10 3 cells/well). Cells were infected with 50 l lentivirus according to TRC protocols and were split 1 day postinfection into three replicate glass-bottom 96-well plates (Matrical) for immunohistochemistry. The medium was then changed daily on the cells to medium containing 2 g/ml puromycin (Sigma) to allow for selection of cells stably expressing shRNA. Five days following infection (4 days of selection), differentiation was induced by changing the medium to DMEM ϩ 2% horse serum with 2 g/ml puromycin (day 0) and proceeded for 6 days until the cells were fixed for immunohistochemistry.
Immunohistochemistry and image analysis. Immunohistochemistry was performed based on a previously described protocol (18) . Cells were fixed with 3% paraformaldehyde and probed using a monoclonal antibody for expression of myosin heavy chain (MYH) (MF-20; Developmental Studies Hybridoma Bank, Iowa City, IA) which was used at a 1:1,000 dilution in 1% goat serum/phosphate-buffered saline. An Alexa488-conjugated anti-mouse IgG secondary antibody was used to image expression and the wells were counterstained with Alexa594-Phalloidin (Invitrogen) at a concentration of 1.5 U/ml and Hoechst 33342 (Invitrogen) at 16 M to visualize actin filaments and nuclei, respectively.
Plates were imaged on a Nikon TE-2000 equipped with an automated stage programmed to image four random fields per well in four channels (Hoechst 33342, Alexa594, Alexa488, and bright field) using the provided software (Leeds, Minneapolis, MN). Bright field images taken at the start of differentiation were also acquired on live cells kept at 37°C using an incubation chamber (Solent Scientific, Segensworth, UK). Image analysis was performed using custom-written software in MATLAB (source code available on request). The fusion index was calculated as the percentage of nucleus-specific pixels that overlap MYH-specific pixels (Hoechst 33342 and Alexa488 positive signal).
RT-PCR analysis of shRNA knock-down lines. Lentiviral production and infection was performed as indicated above. Twenty-four hours postinfection, cells were split into six-well dishes containing DMEM ϩ 20% FBS and 2 g/ml puromycin. Cells were then split once and allowed to become confluent, at which point they were induced to differentiate as indicated above. After 24 h, cells were harvested in 600 l RLT buffer and purified using RNEasy Mini kits (Qiagen, Valencia, CA). Reverse transcription was performed using a High Capacity cDNA RT kit (Applied Biosystems, Streetsville, ON, Canada) and SYBR Green PCR was done using Power SYBR Green PCR master mix (Applied Biosystems). For analysis of myogenic markers, reverse transcription was performed by using iScript cDNA synthesis kit (Bio-Rad) and SYBR Green PCR was done by using the Fig. 1 . Time points sampled during C2C12 differentiation. Differentiating C2C12 myoblasts were sampled at various time points, particularly within the first 24 h of differentiation. RNA was harvested at each time point during 3 successive passes and hybridized to Affymetrix MOE-430 v2 arrays at time points indicated by "A," whereas the "I" time points were hybridized to Illumina mouse WG-6 v1.1 arrays. Platinum SYBR Green qPCR SuperMix-UDG with ROX master mix (Invitrogen). Primers used for analysis are listed in Table 2 . Each reaction was performed in triplicate to ensure accurate quantification and average signals were normalized to signal from the Eif3i control gene.
RESULTS

Microarray profiling of C2C12 myogenesis.
To identify genes that are differentially expressed during C2C12 myogenesis, we profiled gene expression over 6 days in differentiating C2C12 myoblasts. RNA was harvested from three successive passages at 13 time points, 10 of which were from the first 24 h (Fig. 1) . Processed RNA samples were hybridized to Affymetrix MOE-430v2 arrays, which assay transcript levels using 45,102 probe sets, and expression levels were normalized using RMA (8) . The average pair-wise comparison of all biological replicate arrays shows very close agreement (average r 2 ϭ 0.98), indicating that each passage was subject to very low amounts of technical variability (Table 3) .
We identified genes that were differentially expressed during differentiation using Cyber-T, which employs regularized ttests that model expression variances using Bayesian statistics (4) . Differentially expressed probe sets were identified where the FDR of adjusted P values was Ͻ0.1, based on the histogram of adjusted P values. Empirical Bayes approaches have been shown to provide good power while accurately controlling false positive rates for microarray experiments with a small number of replicates (32, 44) . An evaluation of different statistical tests using simulated and spike-in data showed that Cyber-T most accurately reported the expected false positive rates, particularly in data with high variances at low intensities (32) .
Our statistical tests use the 0 h time point as the reference to which the other time points are compared, since C2C12 myoblasts display a certain background rate of differentiation, even in growth medium. As the cells underwent differentiation, the number of differentially expressed genes increased with time, with slightly more genes being downregulated ( Fig. 2A) . The largest change in the number of differentially expressed genes occurred between 12 and 24 h following the induction of differentiation. During this period, we observed a fourfold increase in the number of differentially regulated transcripts, suggesting that critical regulation of C2C12 myogenesis occurred early in the differentiation program. A: differentially expressed genes were determined from robust multiarray average (RMA)-normalized Affymetrix data using Cyber-T, followed by false discovery rate (FDR) correction. B: differentially expressed transcriptional regulators (TRs) were filtered using the TFCAT and Ingenuity Pathway Analysis databases. C: proportion of differentially expressed transcription factors during C2C12 myogenesis. The percentage of differentially expressed TRs is shown in dashed lines, whereas the percentage of all differentially expressed transcripts is shown in solid lines. Upregulated transcripts are indicated by triangles, downregulated transcripts by squares, and the total number of transcripts by circles. The first described wave of regulation in myogenesis involves withdrawal from the cell cycle, including upregulation of Cdkn1a by Myod1 (19, 20) . Shen et al. (41) used BrdU incorporation to determine that the exit from cell cycle occurred within the first 2 days of differentiation, with incorporation rates dropping from 55% to Ͻ3% within that period. The authors measured protein expression levels and demonstrated decreased expression of Ccnd1, Ccna2, Ccne2, and Ccnd1 and increased expression of Ccnd3 and Cdkn1a. These results are concordant with our expression studies, which demonstrated changes in transcript levels for these genes.
Mapping transcriptional regulators. We identified TRs among the differentially expressed genes using the TFCAT database, a manually curated set of human and mouse TRs (17) , and IPA (Ingenuity Systems, http://www.ingenuity.com). We used TFCAT categories "TF gene," "TF gene candidate," or "TF evidence conflict," and IPA genes annotated as "transcription" to identify 1,622 genes encoding TRs. Of these, 864 TRs showed significant changes in expression for at least one time point during differentiation (FDR P Ͻ 0.1, absolute fold change Ͼ 1.2), including 193 TRs differentially expressed within the first 12 h. These regulators form the core of a vast network that alters the expression of 12,506 transcripts (20,087 probe sets; roughly half the array) and leads to the physiological and morphological changes that occur during C2C12 myogenesis.
As with the full expression dataset, a majority of TRs were downregulated during C2C12 myogenesis (Fig. 2B) . As a group, the proportion of TRs that changed was very high, with Ͼ40% of known TRs being differentially expressed at day 4 of differentiation. Compared with the total list of genes, the proportion of TRs that changed was consistently higher at every time point measured. (Fig. 2C) . K-means clustering of differentially expressed TRs divided these regulators into immediate early or late groups (Fig. 3) . The immediate early group contains 19 genes (green) that are upregulated immediately upon stimulation of differentiation and return to control levels within 3-6 h. These include genes involved in the immediate early response, such as Nr4a1 and the Egr family of transcription factors (28, 49) . The late regulated group includes 10 genes (orange) that are induced within the first 5 h and continue to be expressed in differentiated myocytes, including known regulators such as Myog, Mef2c, and Tead4 (6, 22) , but also TRs not previously known to participate in myogenesis ( Table 4) .
Validation of microarray expression data. We then proceeded to extensively validate the expression measurements. RNA obtained at 12 time points in triplicate was hybridized to Illumina Sentrix Mouse-6 (WG-6v1.1) expression beadchips, which share a similar hybridization technology with Affymetrix arrays, but differ in the number of probes assayed per gene and the number of replicate measurements performed for each probe. Illumina expression measurements were normalized using the LUMI Bioconductor package (15) and mapped to Affymetrix probe sets either using the manufacturers' annotation files or aligning probe sequences to mouse coding sequences in RefSeq. In total, 17,529 genes were mapped between the two platforms based on identifiers in Entrez Gene (89.7%) and RefSeq (10.3%). Fold changes calculated from each platform were in close agreement (r 2 ϭ 0.8) over the entire range of response, particularly when fold changes were Ͼ1.2, suggesting that measurements over this value are the most reproducible (data not shown).
As an additional validation of the expression data, 10 genes were selected for RT-PCR analysis. These genes included TRs known to be implicated in myogenesis, as well as regulators showing differential regulation at the early stages in the dif- ferentiation program, such as the immediate early genes Nr4a1 and Nr4a2. We found that fold-change profiles measured with Affymetrix and RT-PCR were concordant for nine out of 10 genes (data not shown).
Selection of shRNA targets. To determine which of the TRs identified from the microarray analysis are essential for C2C12 differentiation, we performed a high-content screen using shRNA constructs. From the 864 differentially expressed probe sets that were mapped to TRs, we selected the 49 most strongly upregulated transcripts during the first 24 h of differentiation (Fig. 4, A and C) . This corresponded to a fold change of 1.5 or more, which shows very good reproducibility between the Affymetrix and Illumina expression platforms (r 2 Ͼ 0.9). To select negative controls, we identified 751 TRs that were expressed at similar levels as the target genes but showed no significant changes in expression during myogenesis. From this group, we randomly selected 24 genes to belong to the negative set (Fig. 4, B and D) . A third "positive control" set of three genes (Myod1, Myf5, and Myf6) was selected based on their well-known involvement in myogenesis.
To validate the specific expression changes in the target and negative sets, we randomly selected 11 genes from the negative set and 32 genes from the target set and measured their transcript levels using RT-PCR. Nine out of 11 genes from the negative set were not differentially expressed at any time point, whereas 29 out of 32 target genes tested were significant for at least one time point (P Ͻ 0.05, Table 5 ). Genes that did not validate were excluded from further analysis.
shRNA knock-down of TRs interferes with differentiation. We used lentiviral-based shRNAs to determine if differentially expressed genes from our expression studies were functionally important for C2C12 myogenesis with an average of five shRNA constructs targeting each target gene (29) . Analysis of previous large-scale studies using shRNA libraries shows that using four to six constructs per gene is ideal, with additional redundancy not providing a higher level of validation (25) . We constructed a custom set of arrayed lentiviral-based shRNA constructs including 401 individual shRNAs (254 target, 118 negative, 19 positive control, and 10 negative control shRNAs targeting EGFP). These constructs were cotransfected with packaging plasmids (transfection efficiency Ͼ75% based on parallel transfections with a green fluorescent protein-expressing plasmid) in 293T cells before harvesting lentivirus in 96-well plates. Proliferating C2C12 cells were infected with each of these lentiviruses (multiplicity of infection ϭ 0.2 Ϯ 0.1) in 96-well plates, and puromycin-resistant cells were grown to confluence prior to inducing differentiation. After 6 days of differentiation, cells were fixed and stained for MYH, nuclei, and actin filaments (Fig. 5) .
Since myogenesis was induced in all wells at the same time, it is possible that variations in the number of cells present at day 0 can influence the ability of the cell population to differentiate. These variations may well be due to the effect of the shRNA infection, as several targets genes are implicated in the cell-cycle (e.g., Myc, Egr1, and Rb1). However, it is difficult to separate this effect from technical artefacts resulting from variations in plating density and virus titer. We therefore only considered wells that were confluent based on bright field images taken at the start of differentiation.
We calculated the fusion index as the proportion of nuclei (Hoechst 33342-positive pixels) that were present in fused cells, based on MYH staining (Alexa488-positive pixels). The images were analyzed automatically using custom software that used an adaptive threshold for the MYH and nuclear channels to differentiate positively stained regions from background. This measure was typically between 40 and 60% in cells where differentiation was not inhibited (Fig. 6) . A separate analysis was performed by automatically counting nuclei using a Watershed segmentation algorithm and scoring events where Ͼ50% of the area or circumference of the nucleus overlapped with an Alexa488-positive region. These methods gave comparable results to the pixel analysis (data not shown). Expression of MYH, as measured by total Alexa488 pixel count, was also used as a measure of differentiation and correlated very well with the fusion index (r 2 ϭ 0.96, data not shown).
All three positive controls inhibited differentiation significantly (P Ͻ 0.01), indicating that our screen worked well (Table 6 ). We were able to identify 42 TRs that, when knocked-down, showed significant differences in their fusion indices compared with controls targeting EGFP and are therefore essential for differentiation of C2C12 myoblasts (Fig. 6) , including 26 genes (53%) from our "target" set.
To test the efficacy of our knock-down constructs, we selected a set of 18 genes and compared their expression in the respective knock-down lines to that in uninfected cells, or cells expressing shRNA to a nongenomic target (anti-GFP_1). Genes were divided into 12 TRs that significantly inhibited differentiation (P Ͻ 0.01 for at least two independent shRNA clones) and six TRs that did not. Of the 18 genes tested, 13 Expression values were measured at all 13 time points in triplicate and compared with the initial timepoint by t-test. Expression values were normalized to 2 control genes, Eef1a1 and Eif3i, and the lowest P value measured across the time points is listed. Genes with P values Ͻ0.05 after normalization with either control gene are listed as significant.
(72%) showed decreased expression by at least 40%, including 9 genes that were knocked down by Ͼ60%. Genes retaining Ͼ80% activity were not considered knocked down. Based on this, we estimate that transcript knockdown was concordant with inhibition of differentiation for 10 of 12 genes (83%, Table 7 ).
Although the target set includes genes with well-established roles in myogenesis, such as Mef2c, Myc, and Atf3, one-third of the genes have not been previously linked to muscle differentiation. Some of these have been implicated in the differentiation of other tissues and may therefore participate in myogenesis through more general mechanisms. For instance, Cops2 interacts with several nuclear receptors as a co-repressor and is known to be involved in neuronal differentiation (1, 2) . Targeted disruption of Cops2 was shown to be embryonic lethal through proliferation defects in cells of the inner cell mass (27) . Plagl1 contributes to cell-cycle arrest at G1 and is involved in the differentiation of a wide range of tissues, including neuron, Fig. 5 . Imaging of cells following shRNA knock-down of target and control genes. Examples of genes that, when knocked down, showed significant inhibition of C2C12 myogenesis. The first column images were taken at the start of differentiation, while columns 2-4 were taken from fixed and stained cells at day 6. Images from column 5 are synthetic composite images obtained from the combination of thresholded images from columns 2 and 3. A: infections for positive and negative control genes; B: infections for genes from the "negative" and "target" sets.
cartilage and muscle (45, 52, 53) . Surprisingly, 13 genes from the "negative" set (54%) significantly inhibited C2C12 myogenesis, despite the fact that they show no differential regulation in our microarray data ( Table 6 ). Most of these genes have little to no previous literature evidence of involvement in myogenesis and are therefore very interesting candidates for further study.
We created stable knock-down lines for three genes from our dataset (Zfp689, Cops2, and Plagl1) for which no prior evidence of involvement in myogenesis had been reported and measured the expression of the known myogenic markers Mef2c and Troponin T1 at different points during differentiation (Fig. 7) . All three knock-down lines showed marked reduction in both myogenic markers at all time points assayed, as well as for the myogenic regulator Myog (data not shown). In particular, knocking down Zfp689, a TR from our negative set, had an even stronger effect on these markers than a Myod1 knock-down line. This data imply that these genes regulate C2C12 myogenesis by controlling the expression of known myogenic regulatory and structural genes.
DISCUSSION
By extensively mapping transcriptional changes in differentiating C2C12 myoblasts, we have identified 26 novel TRs that are critical for myotube formation. C2C12 differentiation is a widely used model of myogenesis, as these cells closely mimic the transcriptional and morphological changes that occur as skeletal muscle differentiates in vivo (55) . However, as it is possible that transcriptional programs will be different within in vivo systems, the genes identified here should be further studied in primary lines and knockout models. Studies using this model and knockout mice have identified a core set of TRs that coordinate the myogenic program, including Myod1, Myf5, Myog, Myf6, and Mef2c. However, the number of genes known to be directly regulated by this small number of factors represents only a fraction of the number of differentially expressed genes reported in high-throughput expression studies (6), motivating our present study to identify additional TRs that are required for C2C12 myogenesis.
Several previous reports have been published assessing transcriptional changes during myogenesis in high-throughput (14, 31, 41, 48, 51) . With the exception of Delgado et al. (14) , these studies used temporal resolutions of 1 day, which may fail to detect early or short-term changes in gene expression. We extended these approaches by sampling at higher temporal densities and validating the importance of our targets through detailed functional studies. To date, this represents the most complete account of genome-wide transcriptional changes in myogenesis. Strikingly, our data show that over half of all known TRs were differentially expressed during C2C12 myogenesis, including almost 200 within the first day. Comparison of our data with a previous study using chromatin immunoprecipitation to identify genes whose promoters are bound by Myod1, Myog, and Mef2 (6) reveals that only 28 differentially expressed TRs (14%) can be explained by direct binding of these factors.
To identify which of these novel regulators are required for C2C12 myogenesis, we performed a high-content screen with a custom set of Ͼ400 lentiviral-based shRNAs to identify functional regulators of myocyte differentiation. We chose lentiviral delivery of shRNA followed by puromycin selection as it ensures stable knockdown of target genes in all cells being assayed throughout the 6-day program of differentiation (10, 34, 47) . However, our shRNA validation strategy comes with certain known challenges. First, previous studies have shown that RNAi expression can stimulate an interferon response (9, 43) . These effects can be minimized by using vector-based shRNA strategies, since data from TRC shows no significant Fig. 6 . Effect of shRNA knock-down on myoblast differentiation. Genes whose knockdowns significantly inhibit differentiation are grouped by set and ranked by residual myogenic fusion index. Genes were included if a minimum of 2 independent shRNA constructs had fusion indices significantly lower than cells infected with shRNA against green fluorescent protein (GFP) (anti-GFP). The fusion index was calculated as the percentage of pixels from a nuclear stain that overlap pixels from a stain for myosin heavy chain, a marker for cell fusion. Individual measurements are the averages of 4 random fields from the knock-down line with the greatest effect. Error bars represent the SD of 3 replicate wells. upregulation of six interferon response genes following shRNA expression [http://www.broad.mit.edu/rnai/trc/lib, (29)]. Second, maturation of the hairpin structure into a catalytic molecule involves cellular components used for processing miRNA that can saturate in transient-transfection siRNA assays (56). Our lentiviral-based targeting strategy benefits from having lower expression levels, since expression is driven from a single integrated construct. Previous experiments have determined that lentiviral-based shRNAs are expressed at levels lower than the top 10 endogenous microRNAs (data not shown). Finally, off-target effects can result from mishybridization of the shRNA target sequence with other transcripts (23) . Targeting specific genes without affecting its homologs or family members therefore requires careful design of the targeting sequence.
As expected, knock-down of TRs with well-known involvement in myogenesis significantly impaired differentiation (Ͼ50%, P Ͻ 10 Ϫ4 ). Moreover, our RT-PCR data show effective knock-down of expression in the majority of genes tested that is highly concordant with the inhibition of differentiation (83% concordance rate, Table 7 ), providing further validation that the screen was successful. Of the TRs differentially expressed within the first 24 h (target set), 53% significantly impaired myotube formation and in some cases completely blocked differentiation. For example Btg2, a gene found in the immediate early cluster of upregulated genes, shows a brief twofold upregulation within the first 2 h of differentiation. This short change in expression is necessary for differentiation to occur, as knock-down of Btg2 severely impaired myotube formation (74% inhibition). This finding is consistent with a recent study showing that G1 arrest in C2C12 cells occurs through upregulation of Btg2 and Ccnd1 and that siRNA knock-down of Btg2 resulted in impaired myogenesis through cell-cycle arrest (16). C2C12 myoblasts were infected with 427 shRNA constructs and allowed to differentiate under selection conditions. Table shows 42 genes with fusion indexes significantly less than the negative control wells (P Ͻ 0.01). Results from the shRNA construct causing the greatest reduction in fusion index for each gene is shown. Also displayed is the number of shRNA hairpins that significantly inhibited differentiation compared to the number tested. Gene names in boldface represent genes not previously implicated in myogenesis.
To our surprise, an almost equal proportion of genes within the negative set, consisting of randomly selected TRs that showed no significant change in expression, were also found to interrupt differentiation when knocked down by shRNA (54% of genes surveyed). Most of these genes have been poorly studied, especially with regard to their involvement in muscle differentiation. However, some have been implicated in the development of other tissues. For instance, Eomes is critical for trophoblast and mesoderm formation (39) and involved in the regulation of neurogenesis (3) . Our data show that Eomes knock-down in C2C12 cells reduces the myogenic fusion index by 67%. Phox2b, a transcription factor whose knock-down inhibits C2C12 myogenesis by 43%, is required for the specification of branchiomotor neurons (37) .
Genes from the negative set constitute TRs that were randomly selected from 769 stably expressed genes. Based on our validation data, this would suggest that as many as 415 additional TRs could be important for myogenesis. How might these genes function in differentiation? It is certainly possible that some of the genes within this set were transiently upregulated at time points that were not sampled, despite the high density of time points used. It is also possible that these TRs may be differentially activated through posttranscriptional mechanisms. This is the case for genes in the Mef2 family, whose activity is extensively controlled by signal transduction pathways resulting in phosphorylation, sumoylation, and protein-protein interactions (33) . Moreover, previous work has shown that the binding of TRs to regulatory sequences can be enhanced by cooperative binding of another TR that is not transcriptionally regulated. For example during early B-cell development, activation of Cd79a requires the coordinate binding of Ebf1, Tcfe2a, and Pax5. Although mRNA levels of Ebf1 and Pax5 are co-regulated with Cd79a, the expression of Tcfe2a (E2A) was shown to remain constant. Instead, Tcfe2a may be regulated by posttranslational mechanisms through interactions with Id proteins (42) . From a systems perspective, the expression state of a gene is the result of multiple inputs, some variable and others persistent, such that disruption of any Genes were divided into 2 sets based on their effects on C2C12 myogenesis (significant or not, signif or not signif, respectively). Residual myogenesis refers to the proportion of fusion index measured compared with cells infected with Anti-GFP_1 shRNA, as reported in Table 2 . Expression values were normalized with the control gene Eif3i and the percent knockdown is calculated as gene-specific expression in shRNA-treated cells compared with uninfected cells. Normalized expression values from cells treated with antiGFP_1 shRNA are shown for comparison. of these inputs should result in a change in target gene expression. More generally, the temporal regulation of a gene is defined by the architecture of the cis-regulatory modules to which the inputs bind, rather than on the dynamics of any one of them (5) .
Over the past decade, microarray studies have accounted for a significant proportion of scientific publications. The analysis and validation of these studies are typically designed to only identify differentially expressed genes as being important in the system under study and are frequently used for network elucidation (13, 46) . However, while it's possible that differentially expressed genes may well be the driving force behind a given phenotype, our study clearly illustrates that several TRs critical for C2C12 myogenesis are not differentially regulated, suggesting that more comprehensive systems of gene regulators are at play in complex processes. As mechanisms on how these factors contribute to differentiation may be gleaned using alternative analyses, the entire collection of fluorescence images is provided to the community in a companion website to enable continued efforts. The data reported here are a valuable resource for determining transcriptional networks, identifying candidate genes for diseases related to myogenesis, and providing insights into the general process of differentiation.
